Literature DB >> 27673408

microRNA-372 Suppresses Migration and Invasion by Targeting p65 in Human Prostate Cancer Cells.

Xiangjie Kong1, Xiaoqiang Qian2, Liujian Duan1, Hailong Liu1, Yingjian Zhu1, Jun Qi1.   

Abstract

Prostate cancer (PCa) is one of the most prevalent malignant tumors. microRNAs (miRNAs) play an important role in cancer initiation, progression, and metastasis, and their roles in PCa are becoming more apparent. In this study, we found that microRNA-372 (miR-372) is downregulated in human PCa and inhibits the proliferation activity, migration, and invasion of DU145 cells. Subsequently, p65 is confirmed as a target of miR-372, and knockdown of p65 expression similarly resulted in decreased proliferation activity, migration, and invasion. CDK8, MMP-9, and prostate-specific antigen were involved in both these processes. Taken together, our results show evidence that miR-372 may function as a tumor suppressor gene by regulating p65 in PCa and may provide a strategy for blocking PCa metastasis.

Entities:  

Keywords:  PCa; invasion; miR-372; migration; p65

Mesh:

Substances:

Year:  2016        PMID: 27673408      PMCID: PMC5165676          DOI: 10.1089/dna.2015.3186

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  41 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  Prostate cancer screening with prostate-specific antigen testing: more answers or more confusion?

Authors:  Eleftherios P Diamandis
Journal:  Clin Chem       Date:  2010-01-21       Impact factor: 8.327

3.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.

Authors:  S A Ezhevsky; H Nagahara; A M Vocero-Akbani; D R Gius; M C Wei; S F Dowdy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  NF-kappa B nuclear localization and its prognostic significance in prostate cancer.

Authors:  L Lessard; A-M Mes-Masson; L Lamarre; L Wall; J-B Lattouf; F Saad
Journal:  BJU Int       Date:  2003-03       Impact factor: 5.588

Review 6.  MicroRNAs and metastasis: little RNAs go a long way.

Authors:  Derek M Dykxhoorn
Journal:  Cancer Res       Date:  2010-07-27       Impact factor: 12.701

Review 7.  Review of diagnostic markers for prostate cancer.

Authors:  Fritz H Schröder
Journal:  Recent Results Cancer Res       Date:  2009

8.  miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2.

Authors:  Wha Ja Cho; Jeong Min Shin; Jong Soo Kim; Man Ryul Lee; Ki Sung Hong; Jun-Ho Lee; Kyoung Hwa Koo; Jeong Woo Park; Kye-Seong Kim
Journal:  Mol Cells       Date:  2009-11-19       Impact factor: 5.034

9.  Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.

Authors:  Ravikumar Aalinkeel; Madhavan P N Nair; Gerald Sufrin; Supriya D Mahajan; Kailash C Chadha; Ram P Chawda; Stanley A Schwartz
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

10.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

Authors:  Christina M Annunziata; R Eric Davis; Yulia Demchenko; William Bellamy; Ana Gabrea; Fenghuang Zhan; Georg Lenz; Ichiro Hanamura; George Wright; Wenming Xiao; Sandeep Dave; Elaine M Hurt; Bruce Tan; Hong Zhao; Owen Stephens; Madhumita Santra; David R Williams; Lenny Dang; Bart Barlogie; John D Shaughnessy; W Michael Kuehl; Louis M Staudt
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

View more
  14 in total

1.  MiR-182 inhibits proliferation, migration, invasion and inflammation of endometrial stromal cells through deactivation of NF-κB signaling pathway in endometriosis.

Authors:  Min Wu; Yi Zhang
Journal:  Mol Cell Biochem       Date:  2021-01-05       Impact factor: 3.396

2.  MiR-372-3p Functions as a Tumor Suppressor in Colon Cancer by Targeting MAP3K2.

Authors:  Yana Li; Fuqiang Li; Chang Feng; Tingting Wu; Yuyang Chen; Junaid Ali Shah; Fei Wang; Yong Cai; Jianfeng Wang; Jingji Jin
Journal:  Front Genet       Date:  2022-03-30       Impact factor: 4.599

3.  MicroRNA-30a functions as tumor suppressor and inhibits the proliferation and invasion of prostate cancer cells by down-regulation of SIX1.

Authors:  Qinghuan Zhu; Hongzhi Li; Yingjie Li; Lining Jiang
Journal:  Hum Cell       Date:  2017-06-01       Impact factor: 4.174

Review 4.  Micrornas in prostate cancer: an overview.

Authors:  Daniela Vanacore; Mariarosaria Boccellino; Sabrina Rossetti; Carla Cavaliere; Carmine D'Aniello; Rossella Di Franco; Francesco Jacopo Romano; Micaela Montanari; Elvira La Mantia; Raffaele Piscitelli; Flavia Nocerino; Francesca Cappuccio; Giovanni Grimaldi; Alessandro Izzo; Luigi Castaldo; Maria Filomena Pepe; Maria Gabriella Malzone; Gelsomina Iovane; Gianluca Ametrano; Paola Stiuso; Lucio Quagliuolo; Daniela Barberio; Sisto Perdonà; Paolo Muto; Maurizio Montella; Piera Maiolino; Bianca Maria Veneziani; Gerardo Botti; Michele Caraglia; Gaetano Facchini
Journal:  Oncotarget       Date:  2017-07-25

5.  miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.

Authors:  Zhuojia Lin; Yanan Lu; Qiuyu Meng; Chen Wang; Xiaonan Li; Yuxin Yang; Xiaoru Xin; Qidi Zheng; Jie Xu; Xin Gui; Tianming Li; Hu Pu; Wujun Xiong; Jiao Li; Song Jia; Dongdong Lu
Journal:  Mol Ther Nucleic Acids       Date:  2018-04-12       Impact factor: 8.886

6.  Identification of Potential Prostate Cancer-Related Pseudogenes Based on Competitive Endogenous RNA Network Hypothesis.

Authors:  Tao Jiang; Junjie Guo; Zhongchun Hu; Ming Zhao; Zhenggang Gu; Shu Miao
Journal:  Med Sci Monit       Date:  2018-06-20

7.  MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting ATAD2 in renal cell carcinoma.

Authors:  Shiqi Ji; Xiaolin Su; Haijian Zhang; Zhixing Han; Yuqian Zhao; Qingjun Liu
Journal:  Oncol Lett       Date:  2018-12-28       Impact factor: 2.967

8.  Downregulation of ULK1 by microRNA-372 inhibits the survival of human pancreatic adenocarcinoma cells.

Authors:  Hongxi Chen; Zhipeng Zhang; Yebin Lu; Kun Song; Xiwu Liu; Fada Xia; Weijia Sun
Journal:  Cancer Sci       Date:  2017-08-10       Impact factor: 6.716

9.  Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis.

Authors:  Zhicong Chen; Yonghao Zhan; Jieshan Chi; Shuyuan Guo; Xinliang Zhong; Anbang He; Jianrong Zheng; Yanqing Gong; Xuesong Li; Liqun Zhou
Journal:  EBioMedicine       Date:  2018-07-21       Impact factor: 8.143

10.  Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κB siRNA Complexed with Functional Peptide-Modified Nano-Micelles.

Authors:  Hisako Ibaraki; Takanori Kanazawa; Minami Owada; Keiko Iwaya; Yuuki Takashima; Yasuo Seta
Journal:  Pharmaceutics       Date:  2020-01-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.